baricitinib Tablets, film coated 2 mg, 4 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
Egypt
GMP approvals
WHO
Comments
Will be available in Q3-2024
Manufacturer #274
This pharmaceutical company, established over three decades ago, boasts a strong presence across numerous regions, including the Middle East and Africa. The company's portfolio encompasses a wide range of products, including prescription and over-the-counter medications, as well as food supplements. Their manufacturing facilities adhere to stringent quality standards, boasting EU and US GMP certifications. The company is known for its dedication to research and development, reflected in its numerous product patents. Their key therapeutic areas include infectious diseases, cardiovascular health, and anti-viral therapies. This commitment to innovation has resulted in a significant impact on patient care, particularly in the field of hepatitis C treatment.

Manufacturer usually replies in 12 days